Autoantibodies to RNA helicase A: A new serologic marker of early lupus

Arthritis and Rheumatism

Volumn 56, Issue 2, 2007, Pages 596-604

  Yamasaki, Yoshioki ^a   Narain, Sonali ^a   Yoshida, Hideo ^a   Hernandez, Liza ^a   Barker, Tolga ^a   Hahn, Paulette C ^a   Sobel, Eric S ^a   Segal, Mark S ^a   Richards, Hanno B ^a   Chan, Edward K L ^a   Reeves, Westley H ^a   Satoh, Minoru ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; ENZYME ANTIBODY; PHOSPHOLIPID ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RIBOSOME PROTEIN; RNA HELICASE; SM ANTIBODY;

ADULT; AFRICAN AMERICAN; AGE; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE COURSE; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGING; ASIAN AMERICANS; AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; DEAD-BOX RNA HELICASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NEOPLASM PROTEINS; RHEUMATIC DISEASES; RIBONUCLEOPROTEINS, SMALL NUCLEAR; TIME FACTORS;

EID: 33847071595     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22329     Document Type: Article

References (33)

1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology [review]. Adv Immunol 1989;44:93-151.
2. Okano Y. Antinuclear antibody in systemic sclerosis (scleroderma) [review]. Rheum Dis Clin North Am 1996;22:709-35.
3. Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies [review]. Rheum Dis Clin North Am 2002;28:859-90, viii.
4. Reeves WH, Narain S, Satoh M. Autoantibodies in systemic lupus erythematosus. In: Koopman WJ, Moreland LW, editors. Arthritis and allied conditions. 15th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1497-521.
5. Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum 1999;42:455-64.
6. Arnett FC, Hamilton RG, Roebber MG, Harley JB, Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988;15:1773-6.
7. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus: identification of racial and socioeconomic influences. Arch Intern Med 1990;150:849-53.
8. McCarty GA, Harley JB, Reichlin M. A distinctive autoantibody profile in black female patients with lupus nephritis. Arthritis Rheum 1993;36:1560-5.
9. Zhang SS, Grosse F. Purification and characterization of two DNA helicases from calf thymus nuclei. J Biol Chem 1991;266:20483-90.
10. Lee CG, Hurwitz J. Human RNA helicase A is homologous to the maleless protein of Drosophila. J Biol Chem 1993;268:16822-30.
11. Westberg C, Yang JP, Tang H, Reddy TR, Wong-Staal F. A novel shuttle protein binds to RNA helicase A and activates the retroviral constitutive transport element. J Biol Chem 2000;275:21396-401.
12. Aratani S, Fujii R, Oishi T, Fujita H, Amano T, Ohshima T, et al. Dual roles of RNA helicase A in CREB-dependent transcription. Mol Cell Biol 2001;21:4460-9.
13. Nakajima T, Uchida C, Anderson SF, Lee CG, Hurwitz J, Parvin JD, et al. RNA helicase A mediates association on CBP with RNA polymerase II. Cell 1997;90:1107-12.
14. Takeda Y, Caudell P, Grady G, Wang G, Suwa A, Sharp GC, et al. Human RNA helicase A is a lupus autoantigen that is cleaved during apoptosis. J Immunol 1999;163:6269-74.
15. 1 mice. Arthritis Rheum 2002;46:2235-44.
16. Satoh M, Mizutani A, Behney KM, Kuroda Y, Akaogi J, Yoshida H, et al. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus. Int Immunol 2003;15:1117-24.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
20. Bohan A. Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
21. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Arm Rheum Dis 2002;61:554-8.
22. Satoh M, Langdon JJ, Hamilton KJ, Richards HB, Panka D, Eisenberg RA, et al. Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. J Clin Invest 1996;97:2619-26.
23. Wang J, Satoh M, Kabir F, Shaw M, Domingo MA, Mansoor R, et al. Increased prevalence of autoantibodies to Ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 2001;44:2367-70.
24. Satoh M, Yamagata H, Watanabe F, Matsushita Y, Sakamoto K, Yoshida K, et al. A case of long-standing classical rheumatoid arthritis complicated by serological and clinical characteristics of systemic lupus erythematosus. Scand J Rheumatol 1993;22:138-40.
25. Satoh M, Yamagata H, Watanabe F, Nakayama S, Ogasawara T, Tojo T, et al. Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in a patient with long-standing Sjögren's syndrome. Lupus 1995;4:63-5.
26. Yamagata H. Akizuki M, Tojo T, Homma M. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases. Scand J Rheumatol Suppl 1986;61:98-101.
27. Weiner ES, Hildebrandt S, Senecal JL, Daniels L. Noell S, Joyal F, et al. Prognostic significance of anticentromere antibodies and anti-topoisomerase 1 antibodies in Raynaud's disease. Arthritis Rheum 1991;34:68-77.
28. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA. et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
29. Satoh M, Weintraub JP, Yoshida H, Shaheen VM, Richards HB, Shaw M, et al. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus. J Immunol 2000;165:1036-43.
30. Nacionales DC, Kelly KM, Lee PY, Zhuang H, Li Y, Weinstein JS, et al. Type I Interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). Am J Pathol 2006;168:1227-40.
31. Richards HB, Satoh M, Shaw M, Libert C, Poli V, Reeves WH. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med 1998;188:985-90.
32. Zhang S, Schlott B, Gorlach M, Grosse F. DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner. Nucleic Acids Res 2004;32:1-10.
33. Satoh M, Ajmani AK, Ogasawara T, Langdon JJ, Hirakata M, Wang J, et al. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome: specific recognition of the phosphorylated (IIO) form by a subset of human sera. J Clin Invest 1994;94:1981-9.